Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $11.10B.
ENTERPRISE VALUE (EV)
$11.10B
ImmunityBio, Inc.
Market Cap
$10.35B
Enterprise Value (EV)
$11.10B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| ImmunityBio, Inc. (IBRX) | $10.35B | $11.10B |
| Globus Medical, Inc. (GMED)vs › | $10.35B | $9.96B |
| Align Technology, Inc. (ALGN)vs › | $10.24B | $9.25B |
| The Ensign Group, Inc. (ENSG)vs › | $10.12B | $12.11B |
| Universal Health Services, Inc. (UHS)vs › | $10.73B | $15.85B |
| Repligen Corporation (RGEN)vs › | $10.08B | $10.17B |
| Molina Healthcare, Inc. (MOH)vs › | $10.02B | $8.98B |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.98B | $10.67B |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $10.98B | $14.31B |
| The Cooper Companies, Inc. (COO)vs › | $11.00B | $13.39B |
Market Cap
$10.35B
Total Debt
$844.44M
Cash
$88.33M
Enterprise Value
$11.10B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
